NFKB1 and non-small cell lung carcinoma: Propofol increases miR-486-5p levels in NSCLC cells and xenograft tumor tissues in a N6-methyladenosine (m6A) dependent manner, thereby inactivating the Ras associated protein 1 (RAP1)-NF-kappaB (NF-κB) axis to increase cisplatin sensitivity in NSCLC [23].